A Study to Develop and Validate Clinical Molecular Genetic Lab Tests for the Confirmation of Biochemical Genetic Test Results

Overview

About this study

The aim of this research study is to develop and validate several clinical molecular genetic lab tests for the confirmation of biochemical genetic test results.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:    

  • De-identified clinical waste specimens from Mayo Clinic or outside facilities and/or appropriate tissues obtained with informed consent from patients with a known diagnosis.

Exclusion Criteria:   

  • Identified samples obtained without informed consent and inappropriate tissue types or degraded tissue samples.
  • In addition, samples will not be collected from, nor will we be consenting, prisoners.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Devin Oglesbee, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20315648

Mayo Clinic Footer